Applying to Clinical Trial: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

Contact this trialFirst, we need to learn more about you.

Corticosteroid

0.02% Betamethasone Sodium Phosphate +1 More for Dry Eye Syndrome

Recruiting0 awardsPhase 2

Saint Louis, Missouri

This trial is testing a new drug, SURF-200, for people experiencing a flare-up of dry eye disease. The drug is in the form of an eye drop, and the trial will involve 120 participants across the United States.

Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.

We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our and .

Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.

By clicking start, you agree to our